SCHEMBL3825604

SCHEMBL3825604

COc1ccc2cnc(-c3ccc(OC)c(OC)c3)cc2c1

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.68
RAB9A P51151 10/20 0.68
CASP3 P42574 2/20 0.68
SENP7 Q9BQF6 2/20 0.68
IDO1 P14902 4/20 0.57
TDO2 P48775 4/20 0.57
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
KDM4E B2RXH2 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27993895 0.86 NPC1 (0.69) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL2457696 0.86 PDGFRB (0.55) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL3825995 0.85 RAB9A (0.50) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL3826253 0.82 RAB9A (0.55) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL2458692 0.81 NPC1 (0.76) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL2428152 0.81 NPC1 (1.00) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL3830664 0.80 NPC1 (0.91) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL13728666 0.79 NPC1 (0.56) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL27912509 0.79 HSD17B1 (0.66) CA12CA1CA2CA7CA9
SCHEMBL12463736 0.79 NPC1 (0.71) NPC1RAB9ACASP3SENP7IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-A2 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS Rexahn Pharmaceuticals, Inc. (US) 2009-09-16 EP disclosed
WO-2008063548-A2 5, 6, OR 7-SUBSTITUTED-S- (HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed